We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Gilead Sciences Inc | NASDAQ:GILD | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| -0.44 | -0.65% | 67.31 | 4,974,151 | 21:30:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 67.32 | 67.35 | 67.89 | 67.185 | 67.87 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Biological Pds,ex Diagnstics | 27.12B | 5.67B | 4.5474 | 14.80 | 83.85B |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 21:37:51 | 1 | 67.35 | USD |
| Date | Time | Source | Headline |
|---|---|---|---|
| 22/1/2024 | 15:23 | DJN | Gilead Down Over 10%, on Pace for Largest Percent Decrease Since December.. |
| 22/1/2024 | 14:32 | DJN | Correction to Gilead Says Trodelvy Trial Didn't Meet Primary Endpoint.. |
| 22/1/2024 | 14:17 | DJN | Gilead Says Trodelvy Lung Cancer Trial Didn't Meet Primary Endpoint |
| 28/11/2023 | 20:08 | DJN | FDA Looking Into All Approved CAR T Therapies on Risk of Cancer in White.. |
| 28/11/2023 | 19:59 | DJN | Cabaletta Bio Down as FDA Looks Into Issues With Several Companies'.. |
| 15/11/2023 | 13:30 | DJN | Arcellx Shares Rise Premarket on Expanded Gilead Collaboration |
| 15/11/2023 | 11:58 | DJN | Gilead Invests Further in Arcellx, Extends Collaboration |
| 09/11/2023 | 18:26 | DJN | Gilead Sciences On Track for Largest Percent Decrease Since September 2022.. |
| 08/11/2023 | 16:08 | DJN | Gilead Sciences on Pace for Largest Percent Decrease Since August 2020 --.. |
| 07/11/2023 | 21:51 | DJN | Gilead Sciences 3Q Results Beat Estimates |
Gilead Sciences (GILD) Share Charts1 Year Gilead Sciences Chart |
|
1 Month Gilead Sciences Chart |
Intraday Gilead Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
